Cargando…
Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375247/ https://www.ncbi.nlm.nih.gov/pubmed/34419552 http://dx.doi.org/10.1016/j.kint.2021.08.007 |
_version_ | 1783740285040197632 |
---|---|
author | Boongird, Sarinya Chuengsaman, Piyatida Phanprasert, Salinnart Kitpermkiat, Rungthiwa Assanatham, Montira Nongnuch, Arkom Kiertiburanakul, Sasisopin Malathum, Kumthorn Phuphuakrat, Angsana Setthaudom, Chavachol Bruminhent, Jackrapong |
author_facet | Boongird, Sarinya Chuengsaman, Piyatida Phanprasert, Salinnart Kitpermkiat, Rungthiwa Assanatham, Montira Nongnuch, Arkom Kiertiburanakul, Sasisopin Malathum, Kumthorn Phuphuakrat, Angsana Setthaudom, Chavachol Bruminhent, Jackrapong |
author_sort | Boongird, Sarinya |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8375247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | International Society of Nephrology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83752472021-08-19 Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report Boongird, Sarinya Chuengsaman, Piyatida Phanprasert, Salinnart Kitpermkiat, Rungthiwa Assanatham, Montira Nongnuch, Arkom Kiertiburanakul, Sasisopin Malathum, Kumthorn Phuphuakrat, Angsana Setthaudom, Chavachol Bruminhent, Jackrapong Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-11 2021-08-19 /pmc/articles/PMC8375247/ /pubmed/34419552 http://dx.doi.org/10.1016/j.kint.2021.08.007 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Boongird, Sarinya Chuengsaman, Piyatida Phanprasert, Salinnart Kitpermkiat, Rungthiwa Assanatham, Montira Nongnuch, Arkom Kiertiburanakul, Sasisopin Malathum, Kumthorn Phuphuakrat, Angsana Setthaudom, Chavachol Bruminhent, Jackrapong Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report |
title | Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report |
title_full | Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report |
title_fullStr | Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report |
title_full_unstemmed | Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report |
title_short | Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report |
title_sort | anti–sars-cov-2 spike protein s1 receptor-binding domain antibody after vaccination with inactivated whole-virus sars-cov-2 in end-stage kidney disease patients: an initial report |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375247/ https://www.ncbi.nlm.nih.gov/pubmed/34419552 http://dx.doi.org/10.1016/j.kint.2021.08.007 |
work_keys_str_mv | AT boongirdsarinya antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport AT chuengsamanpiyatida antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport AT phanprasertsalinnart antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport AT kitpermkiatrungthiwa antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport AT assanathammontira antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport AT nongnucharkom antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport AT kiertiburanakulsasisopin antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport AT malathumkumthorn antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport AT phuphuakratangsana antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport AT setthaudomchavachol antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport AT bruminhentjackrapong antisarscov2spikeproteins1receptorbindingdomainantibodyaftervaccinationwithinactivatedwholevirussarscov2inendstagekidneydiseasepatientsaninitialreport |